The regulatory framework governing life sciences was built on a promise that artificial intelligence (AI) cannot keep. Every approval process, audit trail, and validation protocol in the industry rests on a single assumption inherited from decades of traditional software and manufacturing: that a given input produces a fixed, reproducible, defensible output, every time.
Determinism is the bedrock on which the entire compliance apparatus stands. AI does not stand on it. A probabilistic system produces outputs that are statistical by nature, and asking it to guarantee the same answer twice is to misunderstand what it is. This is the real reason 99% of AI projects in the life sciences never reach production.
Tarini Mohapatra, Co-Founder and Chief Executive Officer (CEO) of TFives, has spent more than 25 years at the intersection of life sciences, regulatory compliance, and technology, and has watched this play out up close. “When compliance comes last, everything costs more and takes longer,” he states, recalling a $1.2 million project stopped at the production gate over issues that were solvable in design.
Why the Old Compliance Model Cannot Hold AI
For traditional software, compliance as a final gate worked because the software was deterministic. A finished system behaved predictably, so validating it at the end was reasonable. It could be tested once, the fixed behavior documented, and then certified. AI dismantles that logic at the foundation, because there is no fixed behavior to certify. The system that passed validation on Monday may produce a different output distribution on Friday, not because it is broken, but because that is what learning systems do.
This is why retrofitting compliance onto an AI system fails so reliably, and why Mohapatra insists it be built into the architecture from day one. The point is not simply that earlier is cheaper, though it is. The point is that a probabilistic system cannot be made compliant after the fact in the same way a deterministic one can. This is because its compliance has to be a property of how it is designed to reason, not a checkpoint it clears at the end.
Designing for compliance from inception is the only way to build a system whose behavior remains defensible even as the model evolves. The organizations that grasp this stop asking how to pass the gate and start asking how to make compliance intrinsic to the architecture itself.
Engineering the Bridge Between Certainty and Probability
The collision becomes concrete in a specific, technical form. Regulators require deterministic guarantees; this rule was applied, this threshold was met, this outcome can be reproduced and audited. The AI underneath offers probabilities, not guarantees. Most teams experience this as an impasse and conclude that meaningful AI is simply incompatible with regulated environments, which is why so many promising initiatives are abandoned. Mohapatra’s argument is that the impasse is an engineering problem, not a law of nature. “Regulators think in certainty. AI thinks in probability,” heexplains, and the work is building systems where both can operate without either being compromised.
In practice, which means wrapping probabilistic models inside deterministic controls, the auditable rules, thresholds, and decision boundaries that translate a statistical output into something a regulator can hold accountable. The AI proposes within a structure that constrains and documents it. This is the part of the problem that separates organizations that deploy AI in life sciences from those that talk about it, because it requires architectural sophistication rather than either blind faith in the model or a blanket rejection of it.
Compliance Has to Move at the Speed of the System It Governs
The final consequence of probabilistic AI is that one-time approval becomes structurally inadequate. A deterministic system could be cleared once because it would not change. An AI system continuously generates new outputs and feeds them into other systems that act on them, so a single approval governs only the first moment of a system that keeps producing. Everything after that approval is, under the old model, ungoverned.
Continuous compliance resolves this by matching the cadence of oversight to the cadence of the technology. Every time the AI generates a result, and every time a downstream system consumes it, the necessary checks are applied in real time rather than assumed based on a one-time certification. Continuous oversight lets a company move at the speed AI allows, while staying inside the rules. It also completes the argument running through Mohapatra’s thinking.
The bottleneck in regulated AI was never compliance. It was infrastructure built for a deterministic world being asked to govern a probabilistic one. Rebuild that infrastructure to be designed-in, reconciled, and continuous, and compliance stops being the wall that blocks innovation. In Mohapatra’s framing, it becomes the fastest path to market.
Follow Tarini Mohapatra on LinkedIn or visit TFives for more insights on compliance infrastructure, life sciences AI, and transforming regulatory governance from a bottleneck into a competitive advantage.
